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Targeted SERS nanosensors measure
physicochemical gradients and free energy
changes in live 3D tumor spheroids†
Lauren E. Jamieson,a Victoria L. Camus,a Pierre O. Bagnaninchi,b Kate M. Fisher,a
Grant D. Stewart,c William H. Nailon,d,e Duncan B. McLaren,f David J. Harrisong and
Colin J. Campbell*a
Use of multicellular tumor spheroids (MTS) to investigate therapies has gained impetus because they have
potential to mimic factors including zonation, hypoxia and drug-resistance. However, analysis remains
diﬃcult and often destroys 3D integrity. Here we report an optical technique using targeted nanosensors
that allows in situ 3D mapping of redox potential gradients whilst retaining MTS morphology and function.
The magnitude of the redox potential gradient can be quantiﬁed as a free energy diﬀerence (ΔG) and
used as a measurement of MTS viability. We found that by delivering diﬀerent doses of radiotherapy to
MTS we could correlate loss of ΔG with increasing therapeutic dose. In addition, we found that resistance
to drug therapy was indicated by an increase in ΔG. This robust and reproducible technique allows
interrogation of an in vitro tumor-model’s bioenergetic response to therapy, indicating its potential as a
tool for therapy development.
Introduction
The microenvironment of cancer, and hence the generation
and distribution of energy by cancer cells and stroma for
growth and survival, is complex. Oxygen gradients are common
and hypoxia is often a feature of the tumor microenvironment
since the blood supply to the mass of rapidly proliferating cells
in vivo is poor due to disordered and leaky vasculature that
fails to deliver oxygen and nutrients uniformly. In addition,
many cancers exhibit the Warburg eﬀect,1 whereby metabolism
shifts away from oxidative phosphorylation (which is optimized
for ATP generation) towards glycolysis, a less energy eﬃcient
metabolism but generating more molecules supportive of rapid
cell proliferation. The metabolic dysregulation associated with
the Warburg eﬀect has been identified as an “Emerging
Hallmark of Cancer” and this altered metabolism may play an
important role in the response of tumors to therapy.2,3
Conventional 2D monolayer tissue culture techniques over-
look microenvironmental eﬀects, but 3D tissue culture tech-
niques such as the formation of multicellular tumor spheroids
(MTS) may provide a better model of tumor structure.4–8 MTS
develop a radial structure with a core that may be necrotic or
quiescent, surrounded by quiescent cells and an outer layer
that contains proliferating cells (Fig. 1); this structure has gra-
dients in oxygen, nutrients and pH (Fig. 1) that mimic gradi-
ents present in vivo.4,7 However, the analysis of MTS models is
more diﬃcult due to their 3D nature and often misses either
temporal or spatial resolution (i.e. fast methods typically
overlook 3D heterogeneity and methods with good spatial
resolution are time intensive and may require fixing and
sectioning).9 Here we report a method for the measurement of
redox potential and pH with spatial and temporal resolution
that may be used to probe MTS metabolic phenotype and
response to radiation and drug treatment in live MTS.
Cellular redox potential is a measure of the oxidizing/
reducing potential of the cellular environment. It is a function
of various factors such as oxygen concentration and metabolic
pathway (e.g. glycolysis provides more reducing equivalents of
NADPH than oxidative phosphorylation, so it may be expected
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that glycolysis will make a cell more reductive). Similarly pH is
a function of hydrogen ion concentration [H+] and changes as
a result of metabolism since lactic acid is a major product of
glycolysis, but not oxidative phosphorylation (Fig. 2).
Currently there is very limited knowledge about the quanti-
tative nature of the redox potential and pH gradients that
develop in cancer models. An analytical technique allowing
quantitative measurement of gradients could be a valuable
tool for screening and monitoring responses to therapies such
as radiation and drug candidates.
We have previously shown that surface enhanced Raman
scattering (SERS) nanosensors can be used to quantitatively
measure redox potential and pH in live cells in monolayer
culture.10–16 The SERS nanosensors used are gold nanoshells
(NS) coated with redox or pH responsive molecules and they
are delivered to the cytosol of cells and report in a ratiometric
manner.17,18 Simultaneous measurements of redox and pH are
important as, for our reporters (and most cellular redox
couples), redox potential is pH dependent and therefore can
only be reported accurately if this is taken into account.16 Eqn
(1) shows the Nernst equation for a two-electron, two-proton
coupled reduction where E is the redox potential of the
environment, Eθ is the standard potential for the redox couple,
n is the number of electrons transferred, F is Faraday’s con-
stant, [Ox] is the concentration of the oxidised form, [Red] is
the concentration of the reduced form and [H+] is the concen-
tration of protons.19
E ¼ Eθ þ RT
2F
ln
½Ox½Hþ2
½Red ð1Þ
Here we show that simultaneous measurements using
redox and pH nanosensors, can be made to calculate a redox
Fig. 1 MTS grow into a spherical structure with outer, intermediate and
core regions, and can support gradients in many important physiological
characteristics.
Fig. 2 A pathway map showing cellular metabolic processes associated with hypoxia – areas likely to have a large bearing on intracellular redox
potential and pH are highlighted.
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potential and probe the response of MTS to drug treatment
with both spatial and temporal resolution. This is accom-
plished by targeting nanosensors to distinct zones of the MTS,
and validating their distribution using photothermal optical
coherence tomography (PTOCT). Nanosensor targeting allows
radial resolution of redox potential using a simple, robust,
fiber-based Raman system that is amenable to high through-
put automation.
Results
Visualizing and controlling 3D nanosensor distribution
In order to measure SERS signals from nanosensors in specific
regions of MTS we developed protocols for targeting nano-
sensors to the core, intermediate and outer zones.
Transmission electron microscopy (TEM) confirmed nano-
sensor delivery with subcellular resolution (see ESI Fig. 1†),
however, TEM fails to provide information on global distri-
bution of NS in whole MTS. To evaluate the eﬃcacy of our
targeting, we used photothermal OCT (PTOCT)20 as it allows
intact MTS to be imaged with appropriate spatial resolution to
show MTS targeting and does not require sectioning or stain-
ing. For PTOCT, nanosensors in the MTS were photothermally
heated by a modulated laser (785 nm), which created a modu-
lation in the phase of the OCT signal over time. The modulated
phase was then Fourier transformed to assign a color for each
pixel (indicating the presence/absence of nanosensors) based
on the presence or absence of phase modulation (see ESI Fig. 2
and 3†).
Photothermal OCT images in Fig. 3 show the localization of
nanosensors in MTS grown using the diﬀerent protocols
described in the Experimental section. Briefly, in order to
target NS to the core of MTS, we seeded MTS with cells con-
taining NS and then subsequently added cells in suspension
that had not been treated with NS. Fig. 3a shows the highest
intensity of photothermal signal in the central region of MTS
indicating successful targeting. A similar technique was used
to deliver NS predominantly to the outer region (proliferating
layer) of the MTS and predominantly to the intermediate
region (quiescent layer) – in each case MTS were seeded with
cells not treated with NS. For delivery to the intermediate
region a suspension of cells that had been treated overnight
with NS were added on the second day of MTS growth and for
delivery to the outer region on the fifth day of MTS growth.
Fig. 3b shows that for the intermediate region NS are between
the core and the outer region (although not uniformly distri-
buted throughout the MTS) and Fig. 3c shows targeting to the
outer zone of the MTS. In a control experiment where MTS
were grown for 6 days from cell suspension containing NS, the
Fig. 3 Targeted SERS nanosensors in MTS imaged using PTOCT. OCT signals (far left column), photothermal signals (central left column), an
overlay of photothermal on OCT signal (central right column) and a schematic of the NS distribution that each condition represents (far right
column). Dimensions apply to all photothermal and OCT images.
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NS are homogeneously distributed through the MTS (Fig. 3d).
By confirming successful NS targeting to the outer, inter-
mediate and core regions of MTS, we can ensure that measure-
ments made in each case come exclusively from the region
being probed. As SERS signals are exclusively obtained from
NS, NS only report on redox and pH of their immediate
environment and thus by confirming successful targeting we
confirm that only the targeted region contributes to SERS
measurements of redox and pH. As each region is targeted
separately, we ensure no mutual interference of SERS spectra
acquired from each region.
Determining gradients in MCF7 MTS using SERS
Redox potential and pH are important conduits of metabolism
and their measurement in MTS should provide important
information on how metabolism is regulated in distinct micro-
environments. Having demonstrated that NS can be targeted
to distinct zones within MTS we next sought to make measure-
ments using pH and redox nanosensors. SERS measurements
were made using a 785 nm laser via a simple fiber optic probe
(see ESI Fig. 4†). Since MTS were grown under identical con-
ditions we used the average pH from each condition to correct
the average redox measurement in order to give a pH-corrected
redox potential in accordance with eqn (1). Fig. 4a and b show
examples of spectra from MBA-NS (pH nanosensor) and
NQ-NS (redox nanosensor) respectively, measured in the core,
intermediate and outer zones of MTS grown from MCF7
(breast cancer) cells.
Combining data from technical and biological replicates we
calculated the redox potential gradient in MCF7 MTS. Fig. 5a
shows that the redox potential, became more reducing going
from the outside to the intermediate and then to the core of
MTS (see ESI Fig. 5† for pH measurements and ESI Tables 1
and 2† for values obtained, and ESI Fig. 6† for an example of
the importance of making pH corrections to redox values).
This redox potential gradient confirms the hypothesis that
intracellular redox potential becomes more reductive (hypoxic)
when moving towards the center of an MTS.
Monitoring MCF7 MTS gradient changes in response to
apoptosis
The gradients generated by MTS are an emergent property of a
viable system (and should dissipate as a result of death) – in
other words, it takes free energy to generate a gradient and in
the absence of free energy input the system will move towards
equilibrium. We therefore propose that the measured gradient
can be used as a measure of MTS viability by converting the
potential gradient to a free energy diﬀerence associated with
viability via ΔG = −nFΔE.
Having established the nature of the redox potential distri-
bution throughout an untreated MTS, we sought to examine
how the gradient changed as the MTS were treated with the
drug staurosporine (STS, a potent tyrosine kinase inhibitor
that induces apoptosis).21 As predicted, after 24 hours the
gradient is dissipated (Fig. 5b) and the resultant free energy is
lower than in the case of the untreated MTS (Fig. 5c). These
findings tie in well with morphological studies of MCF7 cells
treated with STS in 2D that show nuclear condensation, cell
rounding and membrane blebbing (all indicative of apoptosis)
(see ESI Fig. 7†). For pH measurements see ESI Fig. 5 and 6†
and for details of values see ESI Tables 1 and 2.†
By taking the largest diﬀerence in redox potential between
MTS regions and converting to free energy we can see that a
quantitative decrease in free energy is observed upon STS treat-
ment (Fig. 5c). This supports our hypothesis that there is a cor-
relation between loss of the free energy required to maintain a
gradient and loss of viability. ESI Fig. 8† illustrates an indepen-
dent repeat of redox potential gradient response in MCF7 cells
to staurosporine treatment. While the overall trend in free
energy change is consistent between repeats, there are subtle
changes in the gradients observed. This can be attributed to
varying spheroid size between independent data sets and a
further extensive study could investigate the subtle eﬀects of
spheroid size and age on free energy gradient. MCF7 spheroids
had an average diameter of ca. 0.5–1 mm (see ESI Fig. 9†).
Radiation therapy is used to treat nearly 50% of patients
with cancer in the UK and there is an ongoing interest in
Fig. 4 Redox potential and pH gradients in MCF7 MTS measured by SERS. Average SERS spectra acquired for core, intermediate and outer regions
of MTS with targeted MBA-NS (a) and NQ-NS (b) along with a schematic showing average pH and average adjusted redox potential values for each
condition.
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analytical methods that enable the eﬀect of radiation on the
viability of live tumor models to be monitored in order to
improve treatment planning. For this reason and in order to
investigate the extent to which the gradient could be used to
measure relatively subtle diﬀerences in viability we treated
MTS grown from a prostate cancer cell-line (PC3) with radi-
ation of increasing dose from 0 to 8 Gy. MTS were treated with
radiation in a single dose and their pH and redox potential
measured after 24 hours (see ESI Fig. 10† for pH measure-
ments and ESI Tables 3 and 4† for values obtained). When the
pH corrected redox potentials were measured in these MTS
(Fig. 5d–h), it is clear that the potential gradient (Fig. 5i)
decreases with an increase in dose, confirming that this
measure of viability can discriminate between increasing
doses of radiation. The increasing eﬀect of radiation can also
be seen on the morphology of the MTS in ESI Fig. 11,† where
higher doses lead to increased degradation of the MTS. The
PC3 MTS images in ESI Fig. 11† also highlight the slightly
smaller size of PC3 MTS compared to MCF7 MTS with an
average diameter of ca. 0.4–0.5 mm. Again this could explain
the diﬀerence in redox potential values observed in the
untreated spheroids, but could also be a result of the diﬀering
cell lines. The technology developed in this paper would allow
an extensive study into the influence of cell line, MTS size and
age on pH and redox gradients in developing MTS.
Application to cisplatin resistant prostate cancer cell line
In order to investigate whether MTS respond diﬀerently when
treated with a drug to which they have developed resistance,
we used our technique to examine the response of MTS gener-
ated from PC3 cells treated with cisplatin at a concentration at
which they are known to be resistant (50 µM).22 (For compari-
son, ESI Fig. 12 and 13† illustrate the pH and redox gradient
changes, respectively, upon treatment of PC3 MTS with stauro-
sporine.) Firstly, these MTS have a diﬀerent structure with the
most reductive part of the MTS being the intermediate layer.
Fig. 5 Monitoring redox potential gradient in MCF7 MTS in response to STS treatment and PC3 MTS in response to radiation treatment. Boxplots
showing the distribution of values obtained for adjusted redox potential for the core, intermediate and outer regions of MCF7 MTS: (a) before STS
treatment; (b) treated with STS for 24 h; and (c) the free energy associated with the redox gradient for MTS determined from the largest redox poten-
tial diﬀerence before and after STS treatment. Boxplots showing the distribution of values obtained for adjusted redox potential for the core, inter-
mediate and outer regions of PC3 MTS: (d) before radiation treatment; (e) treated with 1 Gy radiation; (f ) treated with 2 Gy radiation; (g) treated with
4 Gy radiation; (h) treated with 8 Gy radiation; and (i) the free energy associated with the redox gradient for MTS determined from the largest redox
potential diﬀerence before and after treatment with varying radiation doses. Boxplots represent the 1st quartile, median and 3rd quartile, whiskers
give 99% values, black circles indicate the mean values and crosses the maximum and minimum values.
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Again this highlights potential size variation eﬀect on redox
gradients between independent experiments. Upon treatment
with cisplatin there was no loss of the initial gradient, sugges-
tive of resistance, and there was an increase in gradient after
24 h cisplatin treatment (Fig. 6) suggestive of a compensatory
anti-oxidant response by resistant cells (see ESI Fig. 14† for pH
data, ESI Fig. 15 and 16† for an independent repeat experi-
ment and ESI Tables 5 and 6† for values). Again, this finding
was in line with morphological measurements of PC3 cells
treated with cisplatin in 2D culture (see ESI Fig. 17†), which
show the cells’ resistance to treatment. Resistance to cisplatin
is known to be mediated in part by free-thiols, and while drug
treatment would be expected initially to cause oxidative stress,
a robust reductive response seems to have been important to
re-establishing and maintaining the MTS viability. This behav-
ior can be seen clearly in Fig. 6f where for PC3 MTS, free
energy remained constant on initial treatment with cisplatin
followed by an increase suggesting maintenance of MTS via-
bility and a strongly compensating response, consistent with
PC3 resistance to cisplatin.
Discussion
We have demonstrated that MTS can be grown such that nano-
sensors are targeted to distinct zones and we confirmed this
targeting using photothermal OCT. Targeting of nanosensors
to MTS allowed us to use a simple fiber optic Raman probe to
measure ‘average’ SERS spectra under diﬀerent conditions to
establish quantitative information about MTS bioenergetics.
As well as providing previously unknown quantitative infor-
mation on these gradients and thus providing potentially vital
information for therapy development, we have demonstrated
the potential for this assay to be used for monitoring response
to therapy. By measuring redox potential gradients, after treat-
ment of MCF7 MTS with the apoptosis inducer STS, we could
observe a loss of redox potential gradient that correlates with a
loss of MTS viability. In order to quantify MTS viability in
terms of potential gradients, we expressed the gradients in
terms of free energy with a loss of free energy indicative of loss
of MTS viability. By treating PC3 MTS with increasing doses of
therapeutic radiation we have demonstrated that the measure-
ment of potential gradients is sensitive to subtle diﬀerences in
MTS viability with MTS gradients decreasing as the dose of
radiation increases. In PC3 MTS (resistant to the drug
cisplatin) treatment with cisplatin showed no initial significant
change in gradient, followed by an increase in gradient that we
suggest is linked to drug resistance.
This newly established method for fast detection of redox
potential gradients in MTS uses a simple, and potentially por-
table, fiber optic probe, and provides a new platform for moni-
toring response to drugs and therapy in this 3D cell model, in
a way that allows 3D integrity to be maintained in live cultures.
Since the radial distribution comes from nanosensor targeting
and not from complex optics, there is great potential for auto-
mation and scale-up. While this proof of concept paper
includes experimental steps that require transfer of the intact
MTS onto a gold coated chip for measurement, we believe that
Fig. 6 Monitoring redox potential in PC3 MTS in response to cisplatin treatment. Boxplots showing the distribution of values obtained for redox
potential for the core, intermediate and outer regions of PC3 MTS with targeted MeNQ-NS: (a) before cisplatin treatment; (b) after treatment with
cisplatin for 1 h; (c) after treatment with cisplatin for 4 h; (d) after treatment with cisplatin for 8 h and; (e) after treatment with cisplatin for 24 h.
Boxplots represent the 1st quartile, median and 3rd quartile, whiskers give 99% values, black circles indicate the mean values and crosses the
maximum and minimum values. (f ) The free energy associated with the redox potential gradient for MTS determined from the largest redox potential
diﬀerence as a function of time after cisplatin treatment.
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this step could be eliminated in an optimized high-throughput
platform. For example, hanging drop plates, which allow MTS
to be formed in a 384 drop array,23 could be used in a Raman
plate-reader setup where Raman measurements would be
taken directly from the MTS growing in the plate since the
SERS enhancement is strong enough for spectra to be acquired
above potential background contributions from glass or plastic
substrates. In this setup it is even possible to take measure-
ments from partially and fully dissociated MTS, which could
result from particular drug treatments. As the MTS has been
structurally destroyed in this case, it is likely that the gradient
would be diminished and, while care must be taken in
interpretation if dissociation occurred, an absolute loss of
gradient could still be used as an eﬃcacy indicator.
Increasing movement is being made towards the use of 3D
cell culture models for drug screening due to their increased
physiological relevance, however current techniques for
probing response of MTS to drug candidates are limited by z
penetration depths in imaging techniques, meaning that MTS
often have to be partially digested and analyzed by flow cyto-
metry, or require extensive processing of fixed and sectioned
samples.4,9 Therefore this novel SERS method for quick quan-
titative assessment of the structure and viability of intact live
MTS could prove to be a vital tool in monitoring response to
drugs and therapy in a 3D culture model and lead to an
improved phenotypic assay for drug candidate selection.
Methods
Nanoshell functionalisation
1,8-Diaza-4,5-dithian-1,8-di(2-chloro-[1,4]-naphthoquinone-3-yl)
octane (NQ) was synthesized according to the previously
reported synthetic route.12 MethylNQ (MeNQ) was synthesized
in our group according to the previously reported synthetic
route (reported as compound 12 by Thomson et al.14). NS were
functionalized with 100 µM NQ (10% EtOH in water), 100 µM
MBA solution (10% EtOH in water) or 100 µM MeNQ
(1% DMSO in water) overnight. Functionalized NS were washed
2–3 times with water.
Nanosensor calibration MBA
Calibration and analysis of spectra was carried out in accord-
ance with Jamieson et al.16 Briefly, ca. 20 µl of poly-L-lysine
(PLL) solution (0.1 mg ml−1) was deposited on the surface of a
gold ‘chip’ (cut glass slide coated with a thin layer of gold)
attached to a larger glass slide. After ca. 2 h the PLL solution
was removed and ca. 20 µl of MBA-NS were added to the same
area and left to dry. A series of buﬀers were prepared with pH
values between 0 and 14. By attaching a well around the gold
‘chip’, buﬀers were added to the ‘chip’ in turn and multiple
spectra acquired by focusing the laser spot from the fibre optic
probe on the area of NS and acquiring each spectrum for
30 s. Intensity of the pH sensitive peaks at ca. 1400 cm−1 and
ca. 1700 cm−1 and the peak at ca. 1590 cm−1 were used to form
calibration plots from which pH values could be determined
for unknown spectra.
Nanosensor calibration NQ
SERS spectroelectrochemistry and analysis of spectra was
carried out as described by Auchinvole et al.12 Briefly, gold
microfabricated electrodes were prepared with a deposition of
NS and self assembled monolayer of NQ. The functionalized
electrode was connected to a potentiostat (along with a refer-
ence and auxiliary electrode) and added to a Petri dish con-
taining phosphate buﬀer. The potentiostat was used to set
redox potential values, and multiple SERS spectra were
acquired for each potential value with a 10 s acquisition time.
Intensity of the redox sensitive peak at ca. 1635 cm−1 and the
peak at ca. 1580 cm−1 were used to form calibration plots from
which redox potential values could be determined for
unknown spectra.
Nanosensor calibration MeNQ
SERS spectroelectrochemistry was carried out as described by
Thomson et al.14 Analysis of spectra was performed in
MATLAB to subtract a 16 point baseline followed by extraction
of peak area from 1500 cm−1 to 1612 cm−1 (peak) and area
from 397 cm−1 and 1750 cm−1 (total) and plotting (total area −
peak area)/(total area) vs. redox potential.
Cell culture and nanoshell delivery to cells
MCF7 human breast cancer cells were cultured in Dulbecco’s
Modified Eagle’s Medium and PC3 prostate cancer cells were
cultured in RPMI 1640 media, in both cases supplemented
with penicillin/streptomycin (10 000 units per ml) and 10%
heat-inactivated Fetal Calf Serum (FCS). Cells were incubated
at 37 °C and 5% CO2 in a humidified incubator.
For MTS growth a hanging drop technique was used. 20 µl
drops of cell suspension were pipetted onto the lid of a petri
dish and approximately 10 ml of media was added to the dish.
The lid containing hanging drops was placed on the petri dish
and MTS grew over a period of 6 days with media added every
other day.
For delivery of SERS nanosensors to diﬀerent regions of
MTS diﬀerent protocols were followed. In all cases, media for
cells growing in monolayer culture was exchanged for serum
free media for 1–2 h. For homogenous distribution of nano-
sensor through MTS, cells in monolayer culture were then
incubated overnight with MBA-NS, NQ-NS or MeNQ-NS at a
concentration of ca. 170 fM before formation of hanging drops
the following day. For nanosensor delivery to central regions of
MTS the same protocol was followed, however on the second
day of MTS growth, 5 µl of media was removed and 10 µl of
cell suspension not treated with nanosensors was added. For
nanosensor delivery to intermediate and outer regions of MTS,
MTS were grown from cells initially not treated with nano-
sensors. For delivery to intermediate region, 5 µl of cell sus-
pension from cells incubated overnight with MBA-NS, NQ-NS
or MeNQ-NS was added on the second day of growth. For
delivery to the outer region, 5 µl of cell suspension from cells
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incubated overnight with MBA-NS, NQ-NS or MeNQ- was
added on the fifth day of growth. Spectra were collected on the
sixth day of growth.
Cellular SERS measurements
On the sixth day of growth, MTS in media were pipetted onto a
gold-coated glass slide. (For PTOCT measurements, MTS were
subsequently fixed in 0.5% glutaraldehyde in PBS or 4% para-
formaldehyde.) For SERS measurements, the laser from the
fibre optic probe was focused on the MTS and a total of 15 SERS
spectra were collected under each condition from at least three
independent MTS. An acquisition time of between 10 s and 30 s
was used for each spectral acquisition. Analysis of spectra was
performed using Origin 9 and MATLAB. Baseline subtraction
was performed followed by extraction of maximum peak inten-
sity or peak area in the regions of interest used for calibration
experiments. These values were used along with calibration data
to determine corresponding pH or redox potential. Redox
potential measurements were adjusted dependent on pH accord-
ing to a variation in half cell potential of probe molecules by
ca. 60 mV per pH unit as previously reported by Thomson et al.14
Staurosporine treatment
Media was removed from hanging drop and replaced with
media containing STS at a concentration of 10 µM. MTS were
analyzed as previously 24 h after STS treatment.
Radiation treatment
MTS were irradiated in a Faxitron Cabinet X-ray System
operated at 180 kV. MTS were exposed to 1 Gy, 2 Gy, 4 Gy and 8 Gy
of radiation and analyzed as previously 24 h after irradiation.
Cisplatin treatment
Media was removed from hanging drop and replaced with
media containing cisplatin at a concentration of 50 µM. MTS
were analyzed as previously 1, 4, 8 and 24 h after cisplatin
treatment.
SERS instrumentation and measurements
SERS spectra were recorded with an Ocean Optics QE65 Pro
spectrometer with fibre optic probe and 785 nm laser with
350 mW power and Spectra Suite software. Spectra were
acquired over a 10–30 s acquisition time. SERS spectra were
processed using WIRE™ 2.0, Origin 9 and MATLAB software.
Aqueous suspensions of NS (2.2 × 109 particles per ml,
3.65 pM) were purchased from Nanospectra Biosciences. NS
had a 150 nm diameter with a 125 nm silica core and 25 nm
gold shell and were resonant at 782 nm.
Photothermal OCT
The system used in this study was similar to the system used
by Pai et al.20 The custom system is built around a commercial
OCT engine (Callisto, Thorlabs) which consist of a spectro-
meter and a superluminescent laser diode (SLD) light source
centred at λo = 930 nm with a FWHM bandwidth of 90 nm,
providing a resolution of 5 μm in tissue.
The light beam was then collimated out of a single mode
fibre onto a pair of galvanometers (Thorlabs), to form a
custom laser scanning head (LSH) that raster the beam into an
inverted microscope (SPi95, Brunel). Two f = 50 mm double
achromats in a telecentric configuration were used as the
imaging lens. As opposed to conventional optical coherence
tomography the system was in a common path configuration
where the first reflection from the sample was used as a refer-
ence. The common path configuration resulted in increased
phase stability rejecting common noise more eﬃciently.
Control and acquisition algorithms were written in labview
and matlab. Spectra were collected at a rate of 1200 spectra per
second. In depth intensity and phase information along the
depth axis, Z, were retrieved by fast Fourier transform of the
spectra after resampling in the k-space.
In order to introduce the excitation infrared laser (785 nm),
we made use of the illumination path of the inverted micro-
scope. The excitation laser was modulated by an optical
shutter operated at 330 mHz frequency, heating the gold nano-
cages at their absorption peak on and oﬀ. Thus producing a
phase modulated at the excitation laser modulation frequency
due to the local variation in temperature induced by the plas-
monics photothermal eﬀect.
The photothermal eﬀect was measured by recording succes-
sive B scans (N = 64) at the same location with an acquisition
frequency of 3 Hz. A typical photothermal in depth spheroid
cross-section dataset consisted of 64 time-lapse images (400 ×
512 pixels (x,z)). Considering the small size of the spheroids,
images were cropped down to 256 pixel in z to speed up image
processing. The time varying phase in each pixel was then
Fourier transformed and filtered in the spectral domain with a
bandpass filter corresponding to the excitation laser frequency.
The amplitude was plotted as a heat map showing the distri-
bution of the gold nanoparticles in the spheroids. In addition,
the mean intensity over successive B scan was calculated to
produce spheroids images. Finally, an overlay was built by
combining the two using the thresholded mean intensity
picture as a mask for the photothermal map.
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